-
Resolving the genetic drivers of head and neck cancer
Time of Update: 2023-01-06
"We found that not only the 9p21 locus on chromosome 9p is involved, but also the 9p24 locus, which may be more important in driving resistance in immune checkpoint therapies; Surprisingly, we found that an increase in these gene regions, at least in the case of HPV-negative head and neck squamous cell carcinoma, was associated with ICT survival benefits.
-
Resolving the genetic drivers of head and neck cancer
Time of Update: 2023-01-06
"We found that not only the 9p21 locus on chromosome 9p is involved, but also the 9p24 locus, which may be more important in driving resistance in immune checkpoint therapies; Surprisingly, we found that an increase in these gene regions, at least in the case of HPV-negative head and neck squamous cell carcinoma, was associated with ICT survival benefits.
-
The study found that women with a family history of breast cancer may not need an early mammogram
Time of Update: 2022-10-25
Women with a first-degree relative diagnosed with breast cancer are often advised to be screened 10 years earlier than the age of diagnosis of the relative, and these women are at average risk in other areas.
-
Zhongke New Life invites you to participate in the single-cell multi-omics and spatial omics summit
Time of Update: 2022-08-30
The laboratory's current research focuses on the development of a new generation of bioinformatics methods and technologies, through the integration and mining of multi-omics big data, to accurately construct and analyze cell regulation maps at the single-cell level and explore its application in biomedicine .
-
Newly discovered rare code of life: another set of codes for genetic reading
Time of Update: 2022-08-12
. The brain and testes appear to be very open to using many different types of codes to produce specific proteins, a new study of the way different tissues read genetic information has found .
-
For solid tumors
Time of Update: 2022-05-19
GCC19CART is a GCC-targeting autologous CAR-T therapy product developed for the solid tumor therapy of relapsed, refractory and metastatic colorectal cancer (R/R mCRC) developed by Stance Bio .
References:[1] Gotecca Ecosystem | FDA grants Fast Track designation to Stansay Bio for colorectal cancer CAR-T therapy products.
-
Preoperative immunotherapy plus chemotherapy improves outcomes in lung cancer patients
Time of Update: 2022-05-14
The addition of the immunotherapy drug nivolumab to preoperative (neoadjuvant) chemotherapy in patients with operable non-small cell lung cancer (NSCLC) reduces the risk of cancer recurrence or death by more than three-fold, results from the CheckMate-816 phase III trial show one .
-
ASCO GI Kangfang Bio, Junshi Bio, and Innovent Announce the Latest Clinical Data
Time of Update: 2022-03-09
Retrieved Jan 22, 2022, from https:// The Phase Ib/II clinical study results of Cardonilide (PD-1/CTLA-4 dual antibody) in the first-line treatment of advanced G/GEJ adenocarcinoma will be released in 2022 ASCO GI.
-
Front Oncol: Characteristics and clinical prognosis of EGFR-mutant NSCLC with meningeal metastasis (LM
Time of Update: 2022-02-19
Taken together, the study showed that osimertinib treatment had better clinical outcomes in patients with EGFR-mutant NSCLC after diagnosis of LM .
Taken together, the study showed that osimertinib treatment had better clinical outcomes in patients with EGFR-mutant NSCLC after diagnosis of LM .
-
AJG: Autoimmune hepatitis patients at significantly increased cancer risk
Time of Update: 2022-02-16
5-fold increased cancer risk over 10 years in patients with AIH compared with age- and sex-matched controls .
5-fold increased cancer risk over 10 years in patients with AIH compared with age- and sex-matched controls .
-
Slovenia's agricultural product prices rose by an average of 20% in October
Time of Update: 2021-12-25
According to news from the Stone News Agency on December 14, according to data released by the Sri Lanka National Bureau of Statistics, the prices of crop products in October increased by an average of 29.
-
BMC Cancer: Efficacy and safety of cisplatin plus etoposide (EP) vs carboplatin plus etoposide (EC) in the treatment of extensive-stage SCLC
Time of Update: 2021-12-24
In summary, studies have shown that there is no significant difference between EC and EP regimens in the first-line treatment of patients with extensive-stage SCLC .
There is no significant difference between EC and EP regimens in the first-line treatment of patients with extensive-stage SCLC .
-
Domestic bivalent HPV vaccine launches new dosage form experts: improve prevention and control awareness and vaccinate as soon as possible
Time of Update: 2021-11-13
Yi Danni, chief physician of the Cervical Disease Diagnosis and Treatment Center of Guangzhou Women's and Children's Medical Center, said that HPV (papilloma virus) vaccination is receiving increasing attention in China, but compared with internationally, the current domestic HPV vaccination rate is relatively low.
-
Trends in Cancer Editor's Choice: Showing the Spirit of Trends
Time of Update: 2021-11-04
Reis from the University of Porto in Portugal published an opinion article, conceiving that glycan targeted therapy has the potential to open a new era of cancer treatment, and discussing the use of cancer-related glycosylation for the development of effective cancer drugs Prospects .
-
Because mitochondria come from bacteria, antibiotics might help treat melanoma
Time of Update: 2021-07-27
Researchers at Leuven University may have discovered a new weapon against melanoma: antibiotics that target the "power" of cancer cells .
This result is optimistic, but we need more research and clinical studies to test the use of antibiotics in the treatment of cancer patients .
